IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+3.55%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
Cap. Flow
-$46.8M
Cap. Flow %
-13.39%
Top 10 Hldgs %
42.96%
Holding
198
New
27
Increased
9
Reduced
43
Closed
22

Top Buys

1
KZR icon
Kezar Life Sciences
KZR
$17.1M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$8.3M
3
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.39M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$11.5M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
$7.89M
3
CMPS
Compass Pathways
CMPS
$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
$6.2M

Sector Composition

1 Healthcare 97.67%
2 Consumer Staples 0.57%
3 Technology 0.35%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NTBL
51
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$1.56M 0.23%
790,838
– –
RNTX
52
Rein Therapeutics, Inc. Common Stock
RNTX
$29M
$1.56M 0.23%
2,763,583
– –
ELDN icon
53
Eledon Pharmaceuticals
ELDN
$155M
$1.52M 0.23%
344,578
– –
OKUR
54
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$1.5M 0.22%
175,000
– –
PHAT icon
55
Phathom Pharmaceuticals
PHAT
$843M
$1.47M 0.22%
74,560
-25,000
-25% -$492K
CNTB
56
Connect Biopharma
CNTB
$111M
$1.35M 0.2%
+262,237
New +$1.35M
MXCT icon
57
MaxCyte
MXCT
$147M
$1.33M 0.2%
130,000
-20,000
-13% -$204K
VSTM icon
58
Verastem
VSTM
$585M
$1.31M 0.19%
637,371
-590,000
-48% -$1.21M
TAOX
59
Tao Synergies Inc. Common Stock
TAOX
$20.9M
$1.24M 0.18%
145,629
-100,000
-41% -$851K
IRON icon
60
Disc Medicine
IRON
$2.14B
$1.23M 0.18%
421,050
– –
AVTX icon
61
Avalo Therapeutics
AVTX
$139M
$1.22M 0.18%
718,705
– –
GRI icon
62
GRI Bio
GRI
$3.67M
$1.18M 0.18%
198,085
– –
SYBX icon
63
Synlogic
SYBX
$17.4M
$1.17M 0.17%
483,818
-305,000
-39% -$738K
PLRX icon
64
Pliant Therapeutics
PLRX
$105M
$1.17M 0.17%
86,712
– –
RIGL icon
65
Rigel Pharmaceuticals
RIGL
$710M
$1.16M 0.17%
+439,356
New +$1.16M
CRVS icon
66
Corvus Pharmaceuticals
CRVS
$419M
$1.16M 0.17%
482,610
-274,935
-36% -$663K
BCLI
67
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.16M 0.17%
289,550
– –
QSI icon
68
Quantum-Si Incorporated
QSI
$217M
$1.14M 0.17%
144,406
– –
ASND icon
69
Ascendis Pharma
ASND
$12.1B
$1.13M 0.17%
+8,400
New +$1.13M
DBVT
70
DBV Technologies
DBVT
$249M
$1.08M 0.16%
310,110
– –
ANEB icon
71
Anebulo Pharmaceuticals
ANEB
$101M
$1.07M 0.16%
172,309
– –
CASI icon
72
CASI Pharmaceuticals
CASI
$36.1M
$978K 0.15%
1,223,067
– –
VTGN icon
73
VistaGen Therapeutics
VTGN
$113M
$927K 0.14%
475,693
-125,000
-21% -$244K
SLDB icon
74
Solid Biosciences
SLDB
$448M
$911K 0.14%
521,155
– –
CYCN icon
75
Cyclerion Therapeutics
CYCN
$7.75M
$866K 0.13%
502,627
– –
1 2
3
4 5